Mirum grabs breakthrough designation for liver drug

Mirum Pharmaceuticals announced that the U.S. FDA has granted Breakthrough Therapy Designation for maralixibat for the treatment of pruritus associated with Alagille syndrome
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news